Application of targeted proteomics to metabolically engineered <i><scp>E</scp>scherichia coli</i>

As synthetic biology matures to compete with chemical transformation of commodity and high‐value compounds, a wide variety of well‐characterized biological parts are needed to facilitate system design. Protein quantification based on selected‐reaction monitoring ( SRM ) mass spectrometry compliments metabolite and transcript analysis for system characterization and optimizing flux through engineered pathways. By using SRM quantification, we assayed red fluorescent protein ( RFP ) expressed from plasmids containing several inducible and constitutive promoters and subsequently assessed protein production from the same promoters driving expression of eight mevalonate pathway proteins in E scherichia coli . For each of the promoter systems, the protein level for the first gene in the operon followed that of RFP , however, the levels of proteins produced from genes farther from the promoter were much less consistent. Second, we used targeted proteomics to characterize tyrosine biosynthesis pathway proteins after removal of native regulation. The changes were not expected to cause significant impact on protein levels, yet significant variation in protein abundance was observed and tyrosine production for these strains spanned a range from less than 1 mg/L to greater than 250 mg/L. Overall, our results underscore the importance of targeted proteomics for determining accurate protein levels in engineered systems and fine‐tuning metabolic pathways.